High-Resolution Melting and Real-Time Pcr for Quantification and Detection of Drug-Resistant HBV Mutants in a Single Amplicon
Author(s) -
ChiaChieh Hsiao,
Juliana Chang,
Jeng-You Wu,
Wan-Hsin Liu,
Shih-Yun Han,
PeiJer Chen,
Shiou-Hwei Yeh
Publication year - 2011
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp2022
Subject(s) - entecavir , lamivudine , adefovir , high resolution melt , amplicon , hepatitis b virus , virology , mutant , population , viral load , biology , melting curve analysis , real time polymerase chain reaction , hepatitis b , medicine , virus , polymerase chain reaction , gene , genetics , environmental health
Antiviral therapy by nucleoside/nucleotide analogues (NAs) effectively reduces HBV replication in chronic hepatitis B (CHB) patients. Because long-term NA treatments will eventually select for drug-resistant mutants, early detection of mutants and frequent monitoring of viral loads is crucial for successful NA therapy. Because no efficient test for one-tube quantification and qualification of various HBV-resistant mutants exists, we propose to use high-resolution melting (HRM) analysis in combination with real-time PCR to achieve this unmet need.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom